Photocure

Photocure company information, Employees & Contact Information

Explore related pages

Related company profiles:

About Photocure Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com On this account Photocure posts about uro-oncology and company activity. All information presented on this account is for informational purposes only and is not intended as a substitute for informed medical advice or recommendations from healthcare professionals. Please consult a healthcare professional for more information about your condition and medicinal products.

Company Details

Employees
123
Founded
-
Address
Hoffsveien 4, Oslo,0275,norway
Phone
(609)759-6500
Email
in****@****cure.no
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Oslo
Looking for a particular Photocure employee's phone or email?

Photocure Questions

News

Photocure ASA: Invitation to presentation of third quarter 2025 financial results - TradingView

Photocure ASA: Invitation to presentation of third quarter 2025 financial results TradingView

Photocure ASA Advances Bladder Cancer Treatment with Ongoing Study - TipRanks

Photocure ASA Advances Bladder Cancer Treatment with Ongoing Study TipRanks

Can Photocure ASA (PHS) stock sustain double digit ROE - Portfolio Gains Report & Smart Investment Allocation Insights - Fundação Cultural do Pará

Can Photocure ASA (PHS) stock sustain double digit ROE - Portfolio Gains Report & Smart Investment Allocation Insights Fundação Cultural do Pará

Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy - BeBeez International

Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy BeBeez International

Photocure ASA’s AI-Enhanced Blue Light Cystoscopy: A New Era in Bladder Cancer Detection - TipRanks

Photocure ASA’s AI-Enhanced Blue Light Cystoscopy: A New Era in Bladder Cancer Detection TipRanks

Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy - TradingView

Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy TradingView

Earnings call transcript: Photocure’s Q2 2025 revenue beats expectations, stock surges - Investing.com

Earnings call transcript: Photocure’s Q2 2025 revenue beats expectations, stock surges Investing.com

Photocure ASA to Announce Q3 2025 Financial Results - TipRanks

Photocure ASA to Announce Q3 2025 Financial Results TipRanks

Photocure Q2 2025 presentation: Record revenue growth amid strategic expansion - Investing.com

Photocure Q2 2025 presentation: Record revenue growth amid strategic expansion Investing.com

Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview® - PR Newswire

Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview® PR Newswire

Blue light cystoscopy significantly decreases risk of recurrence in NMIBC - Urology Times

Blue light cystoscopy significantly decreases risk of recurrence in NMIBC Urology Times

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China - Notimérica

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China Notimérica

photocure resins capacity in Asia - Arkema Global

photocure resins capacity in Asia Arkema Global

Photocure Partners with ISC for AI-Enhanced Bladder Cancer Detection - TipRanks

Photocure Partners with ISC for AI-Enhanced Bladder Cancer Detection TipRanks

Photocure Seeks Expanded Use of Blue Light Cystoscopy - Renal and Urology News

Photocure Seeks Expanded Use of Blue Light Cystoscopy Renal and Urology News

Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting - Finansavisen

Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting Finansavisen

Expanded role for Cysview® (hexaminolevulinate HCl) in treating bladder cancer patients -- presented at the 2019 AUA Annual Meeting - PR Newswire

Expanded role for Cysview® (hexaminolevulinate HCl) in treating bladder cancer patients -- presented at the 2019 AUA Annual Meeting PR Newswire

Ipsen Pays PhotoCure and GE Healthcare €19M for Commercialization Rights to Hexvix - Genetic Engineering and Biotechnology News

Ipsen Pays PhotoCure and GE Healthcare €19M for Commercialization Rights to Hexvix Genetic Engineering and Biotechnology News

Arkema starts a 30% photocure resin production capacity increase at its Sartomer site in China - Arkema Global

Arkema starts a 30% photocure resin production capacity increase at its Sartomer site in China Arkema Global

Photocure: A Licensing Deal For Cevira - Investing.com

Photocure: A Licensing Deal For Cevira Investing.com

Progress: New in Town/Start-Ups - communitynews.org

Progress: New in Town/Start-Ups communitynews.org

Top Photocure Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant